1,549
Views
8
CrossRef citations to date
0
Altmetric
Review

Meningococcal infections among refugees and immigrants: silent threats of past, present and future

ORCID Icon & , on behalf of Global Meningococcal Initiative
Pages 2781-2786 | Received 25 Jan 2020, Accepted 15 Mar 2020, Published online: 29 Apr 2020

References

  • [accessed 2020 Jan 01]. https://www.who.int/migrants/en/.
  • [accessed 2020 Jan 01]. https://www.unhcr.org/uk/figures-at-a-glance.html.
  • Report on the health of refugees and migrants in the WHO European Region. [accessed 2020 Jan 01]. http://www.euro.who.int/__data/assets/pdf_file/0004/392773/ermh-eng.pdf?ua=1.
  • [accessed 2020 Jan 01]. https://www.iom.int/news/mediterranean-migrant-arrivals-reach-72263-2019-deaths-reach-1041.
  • Gushulak BD, MacPherson DW. Globalization of infectious 12. diseases: the impact on migration. Clin Infect Dis. 2004;38(12):1742–48. doi:10.1086/421268.
  • Gushulak B, Weekers J, Macpherson D. Migrants and emerging public health issues in a globalized world: threats, risks and challenges, an evidence-based framework. Emerg Health Threats J. 2009;2:e10.
  • MacPherson DW, Gushulak BD, Baine WB, Bala S, Gubbins PO, Holtom P, Segarra-Newnham M. Population mobility, globalization, and antimicrobial drug resistance. Emerg Infect Dis. 2009;15:1727–32.
  • Ergönül Ö, Tülek N, Kayı I, Irmak H, Erdem O, Dara M. Profiling infectious diseases in Turkey after the influx of 3.5 million Syrian refugees. Clin Microbiol Infect. 2020;26(3):307–12.
  • Acevedo R, Bai X, Borrow R, Caugant DA, Carlos J, Ceyhan M, Christensen H, Climent Y, De Wals P, Dinleyici EC, et al. The global meningococcal initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Rev Vaccines. 2019;18(1):15–30. doi:10.1080/14760584.2019.1557520.
  • Bai X, Borrow R, Bukovski S, Caugant DA, Culic D, Delic S, Dinleyici EC, Eloshvili M, Erdősi T, Galajeva J, et al. Prevention and control of meningococcal disease: updates from the global meningococcal initiative in Eastern Europe. J Infect. 2019;79(6):528–41. doi:10.1016/j.jinf.2019.10.018.
  • Moore PS, Toole MJ, Nieburg P, Waldman RJ, Broome CV. Surveillance and control of meningococcal meningitis epidemics in refugee populations. Bull World Health Organ. 1990;68:587–96.
  • Lam E, McCarthy A, Brennan M. Vaccine-preventable diseases in humanitarian emergencies among refugee and internally-displaced populations. Hum Vaccin Immunother. 2015;11(11):2627–36. doi:10.1080/21645515.2015.1096457.
  • Feldsteln B, Wei R. Cambodian disaster relief: refugee camp medical care. Am J Public Health. 1982;72:589–94. doi:10.2105/AJPH.72.6.589.
  • CDC Monograph. Preblud SR, Horan JM, Davis CE. Meningoccal disease among Khmer refugees in Thailand. In: Allegra DT, Nieburg P, Grabe M, editors. Emergency refugee health care – a chronicle of the Khmer refugee – assistance operation 1979–1980. Atlanta GA: CDC. p. 65–69.
  • Haelterman E, Boelaert M, Suetens C, Blok L, Henkens M, Toole MJ. Impact of a mass vaccination campaign against a meningitis epidemic in a refugee camp. Trop Med Int Health. 1996;1(3):385–92. doi:10.1046/j.1365-3156.1996.d01-49.x.
  • Heyman SN, Ginosar Y, Niel L, Amir J, Marx N, Shapiro M, Maayan S. Meningococcal meningitis among Rwandan refugees: diagnosis, management, and outcome in a field hospital. Int J Infect Dis. 1998;2(3):137–42. doi:10.1016/S1201-9712(98)90115-1.
  • Santaniello-Newton A, Hunter PR. Management of an outbreak of meningococcal meningitis in a Sudanese refugee camp in Northern Uganda. Epidemiol Infect. 2000;124(1):75–81. doi:10.1017/S0950268899003398.
  • Stefanelli P, Neri A, Vacca P, Picicco D, Daprai L, Mainardi G, Rossolini GM, Bartoloni A, Anselmo A, Ciammaruconi A, et al. Meningococci of serogroup X clonal complex 181 in refugee camps, Italy. Emerg Infect Dis. 2017;23(5):870–72. doi:10.3201/eid2305.161713.
  • Stefanelli P, Fazio C, Neri A, Rezza G, Severoni S, Vacca P, Fasciana T, Bisbano A, Di Bernardo F, Giammanco A. Imported and Indigenous cases of invasive meningococcal disease W:P1.5,2: F1-1:ST-11 in migrants’ reception centers. Italy, June–November 2014. Adv Exp Med Biol. 2016;897:81–83.
  • [accessed 2019 Mar 09]. http://www.gam.gov.tr/en/.
  • Tezer H, Ozkaya-Parlakay A, Kanik-Yuksek S, Gülhan B, Güldemir D. A Syrian patient diagnosed with meningococcal meningitis serogroup B. Hum Vaccin Immunother. 2014;10(8):2482. doi:10.4161/hv.28951.
  • Ozkaya-Parlakay A, Kanik-Yuksek S, Gulhan B, Tezer H, Altay F, Unal-Sahin N. A refugee patient with meningococcal meningitis type B. Hum Vaccin Immunother. 2018;14(9):2329. doi:10.1080/21645515.2018.1471307.
  • Akyol O, Ozkaya-Parlakay A, Uluman E, Gulhan B, Bedir Demirdag T, Nar-Otgun S. A Syrian refugee with meningococcal empyema. Hum Vaccin Immunother. 2020 Jan;10:1. doi:10.1080/21645515.2019.1700715.
  • Tafuri S, Prato R, Martinelli D, Germinario C. Prevalence of carriers of Neisseria meningitidis among migrants: is migration changing the pattern of circulating meningococci? J Travel Med. 2012;19(5):311–13. doi:10.1111/j.1708-8305.2012.00630.x.
  • Mipatrini D, Stefanelli P, Severoni S, Rezza G. Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence. Pathog Glob Health. 2017;111(2):59–68. doi:10.1080/20477724.2017.1281374.
  • Charania NA, Gaze N, Kung JY, Brooks S. Vaccine-preventable diseases and immunisation coverage among migrants and non-migrants worldwide: A scoping review of published literature, 2006 to 2016. Vaccine. 2019 May 6;37(20):2661–69. doi:10.1016/j.vaccine.2019.04.001.
  • Shetty AK. Infectious Diseases among Refugee Children. Children (Basel). 2019;6:E129.
  • Mitchell T, Weinberg M, Posey DL, Cetron M. Immigrant and refugee health: a centers for disease control and prevention perspective on protecting the health and health security of individuals and communities during planned migrations. Pediatr Clin North Am. 2019;66(3):549–60. doi:10.1016/j.pcl.2019.02.004.
  • Chin T, Buckee CO, Mahmud AS. Quantifying the success of measles vaccination campaigns in the Rohingya refugee camps. Epidemics. 2020;30:100385. doi:10.1016/j.epidem.2020.100385.
  • Thijssen M, Lemey P, Amini-Bavil-Olyaee S, Dellicour S, Alavian SM, Tacke F, Verslype C, Nevens F, Pourkarim MR. Mass migration to Europe: an opportunity for elimination of hepatitis B virus? Lancet Gastroenterol Hepatol. 2019;4(4):315–23. doi:10.1016/S2468-1253(19)30014-7.
  • Hvass AMF, Wejse C. High coverage of polio immunization program in refugees resettling in Denmark. A cross-sectional study of polio serology in newly arrived refugees. Expert Rev Vaccines. 2019;18(12):1317–22. doi:10.1080/14760584.2019.1698953.
  • Ravensbergen SJ, Nellums LB, Hargreaves S, Stienstra Y, Friedland JS, ESGITM Working Group on Vaccination in Migrants. National approaches to the vaccination of recently arrived migrants in Europe: A comparative policy analysis across 32 European countries. Travel Med Infect Dis. 2019;27:33–38. doi:10.1016/j.tmaid.2018.10.011.
  • Giambi C, Del Manso M, Marchetti G, Olsson K, Adel Ali K, Declich S; Venice survey working group. Immunisation of migrants in EU/EEA countries: policies and practices. Vaccine. 2019;37(36):5439–51. doi:10.1016/j.vaccine.2019.06.068.
  • Freidl GS, Tostmann A, Curvers M, Ruijs WLM, Smits G, Schepp R, Duizer E, Boland G, de Melker H, van der Klis FRM, et al. Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016. Vaccine. 2018;36(12):1664–72. doi:10.1016/j.vaccine.2018.01.079.
  • Seedat F, Hargreaves S, Nellums LB, Ouyang J, Brown M, Friedland JS. How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review. Lancet Infect Dis. 2018;18(9):e259–e271. doi:10.1016/S1473-3099(18)30117-8.
  • American Academy of Pediatrics Council on Community Pediatrics. Providing care for immigrant, migrant, and border children. Pediatrics. 2013;131:e2028–e2034. doi:10.1542/peds.2013-1099.
  • Fahrni O, Posfay-Barbe KM, Wagner N. Immunization against hepatitis A in migrant children: three vaccination strategies, a retrospective study. Pediatr Infect Dis J. 2020;39(2):164–69. doi:10.1097/INF.0000000000002526.
  • Hui C, Dunn J, Morton R, Staub LP, Tran A, Hargreaves S, Greenaway C, Biggs BA, Christensen R, Pottie K. Interventions to improve vaccination uptake and cost effectiveness of vaccination strategies in newly arrived migrants in the EU/EEA: a systematic review. Int J Environ Res Public Health. 2018 Sep 20;15:10. doi:10.3390/ijerph15102065.
  • van Zandvoort K, Checchi F, Diggle E, Eggo RM, Gadroen K, Mulholland K, McGowan CR, le Polain de Waroux O, Rao VB, Satzke C, et al. Pneumococcal conjugate vaccine use during humanitarian crises. Vaccine. 2019;37(45):6787–92. doi:10.1016/j.vaccine.2019.09.038.
  • Louka C, Chandler E, Ranchor AV, Broer H, Pournaras S, Ravensbergen SJ, Stienstra Y. Asylum seekers’ perspectives on vaccination and screening policies after their arrival in Greece and The Netherlands. PLoS One. 2019;14(12):e0226948. doi:10.1371/journal.pone.0226948.